Division 3.2.1
United Kingdom
Anti-adrenergics
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Carazolol | Carazolol | Porcine | 5 μg/kg | Muscle | |
| 5 μg/kg | Skin and fat | ||||
| 25 μg/kg | Liver | ||||
| 25 μg/kg | Kidney |
United Kingdom
Anti-adrenergics
| Pharmacologically active substance(s) | Marker residue | Animal species | MRLs | Target tissues | Other provisions |
|---|---|---|---|---|---|
| Carazolol | Carazolol | Porcine | 5 μg/kg | Muscle | |
| 5 μg/kg | Skin and fat | ||||
| 25 μg/kg | Liver | ||||
| 25 μg/kg | Kidney |